Photocure ASA's (OB:PHO) Shares Leap 29% Yet They're Still Not Telling The Full Story
Dec 21
Have your own idea? Try our Stock Screener
Norwegian (OSEAX) Pharma Industry Analysis
UpdatedJan 30, 2025
DataAggregated Company Financials
Companies5
- 7D3.5%
- 3M-1.3%
- 1Y-15.1%
- YTD-7.0%
Over the last 7 days, the Pharma industry has risen 1.6%, driven by gains from Photocure of 8.3%. In the same time, Oncoinvent was down 13%. In the past year, the industry is down 17%. Earnings are forecast to grow by 80% annually.
Industry Valuation and Performance
Has the Norwegian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 Jan 2025 | NOK 3.2b | NOK 1.5b | NOK 22.4m | 21.8x | 144x | 2.2x |
| Sat, 28 Dec 2024 | NOK 3.3b | NOK 1.5b | NOK 22.4m | 23.3x | 146.4x | 2.2x |
| Mon, 25 Nov 2024 | NOK 2.9b | NOK 1.5b | NOK 34.6m | 23.3x | 83.3x | 1.9x |
| Wed, 23 Oct 2024 | NOK 3.2b | NOK 1.5b | NOK 45.2m | 22x | 70.1x | 2.1x |
| Fri, 20 Sep 2024 | NOK 3.2b | NOK 1.5b | NOK 45.2m | 21.4x | 70.1x | 2.1x |
| Sun, 18 Aug 2024 | NOK 2.9b | NOK 1.5b | NOK 93.8m | 23.3x | 30.4x | 1.9x |
| Tue, 16 Jul 2024 | NOK 3.1b | NOK 1.5b | NOK 49.7m | 173.2x | 62.8x | 2.1x |
| Thu, 13 Jun 2024 | NOK 3.4b | NOK 1.5b | NOK 7.6m | 188.7x | 452.3x | 2.3x |
| Sat, 11 May 2024 | NOK 3.2b | NOK 1.5b | NOK 3.0m | 2943.2x | 1074.6x | 2.2x |
| Mon, 08 Apr 2024 | NOK 3.2b | NOK 1.5b | NOK 7.6m | 163.6x | 421.1x | 2.2x |
| Wed, 06 Mar 2024 | NOK 3.3b | NOK 1.5b | NOK 33.1m | 167.4x | 98.2x | 2.2x |
| Fri, 02 Feb 2024 | NOK 3.5b | NOK 1.4b | NOK 18.6m | 25.5x | 188.9x | 2.5x |
| Sun, 31 Dec 2023 | NOK 3.5b | NOK 1.4b | NOK 18.6m | 24.7x | 190.1x | 2.5x |
| Tue, 28 Nov 2023 | NOK 3.0b | NOK 1.4b | NOK 18.6m | 24.1x | 161.6x | 2.1x |
| Thu, 26 Oct 2023 | NOK 3.2b | NOK 1.3b | -NOK 38,433,125.00 | 51.9x | -83.6x | 2.4x |
| Sat, 23 Sep 2023 | NOK 3.4b | NOK 1.3b | -NOK 53,836,125.00 | 52.9x | -62.9x | 2.5x |
| Mon, 21 Aug 2023 | NOK 2.8b | NOK 1.3b | -NOK 60,691,125.00 | 80x | -45.7x | 2.1x |
| Wed, 19 Jul 2023 | NOK 3.0b | NOK 1.2b | -NOK 60,357,125.00 | 74.8x | -49.9x | 2.4x |
| Fri, 16 Jun 2023 | NOK 3.2b | NOK 1.2b | -NOK 104,503,000.00 | 79.3x | -30.3x | 2.6x |
| Sun, 14 May 2023 | NOK 3.2b | NOK 1.2b | -NOK 104,474,000.00 | 75.4x | -30.4x | 2.6x |
| Tue, 11 Apr 2023 | NOK 3.2b | NOK 1.1b | -NOK 140,813,000.00 | 23.9x | -22.5x | 2.9x |
| Thu, 09 Mar 2023 | NOK 3.5b | NOK 1.1b | -NOK 140,813,000.00 | 22.5x | -25.1x | 3.3x |
| Sat, 04 Feb 2023 | NOK 4.6b | NOK 1.0b | -NOK 148,546,289.00 | 46.3x | -31x | 4.5x |
| Mon, 02 Jan 2023 | NOK 4.4b | NOK 1.0b | -NOK 148,546,289.00 | 49x | -29.9x | 4.4x |
| Wed, 30 Nov 2022 | NOK 4.1b | NOK 1.0b | -NOK 148,546,289.00 | 48.2x | -27.9x | 4.1x |
| Fri, 28 Oct 2022 | NOK 3.8b | NOK 940.6m | -NOK 141,575,289.00 | 75.4x | -26.6x | 4x |
| Sun, 25 Sep 2022 | NOK 3.6b | NOK 940.6m | -NOK 141,575,289.00 | 76.7x | -25.7x | 3.9x |
| Tue, 23 Aug 2022 | NOK 4.2b | NOK 896.3m | -NOK 145,675,289.00 | 155.3x | -29x | 4.7x |
| Thu, 21 Jul 2022 | NOK 4.5b | NOK 885.3m | -NOK 151,605,000.00 | 472.8x | -30x | 5.1x |
| Sat, 18 Jun 2022 | NOK 4.4b | NOK 922.8m | -NOK 127,667,000.00 | 82.2x | -34.1x | 4.7x |
| Mon, 16 May 2022 | NOK 4.3b | NOK 922.8m | -NOK 127,667,000.00 | 79x | -33.3x | 4.6x |
| Wed, 13 Apr 2022 | NOK 4.7b | NOK 925.5m | -NOK 91,613,000.00 | 422.3x | -51.7x | 5.1x |
| Fri, 11 Mar 2022 | NOK 4.1b | NOK 925.5m | -NOK 91,613,000.00 | 372.5x | -44.9x | 4.4x |
| Sun, 06 Feb 2022 | NOK 4.5b | NOK 878.6m | -NOK 47,574,665.00 | 197.8x | -93.6x | 5.1x |
Price to Earnings Ratio
-93.6x
Current Industry PE
- Investors are optimistic on the Norwegian Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 141x which is higher than its 3-year average PE of 31.9x.
- The 3-year average PS ratio of 3.1x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 19% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Norwegian Healthcare industry?
| NO Market | 1.24% | |
| Healthcare | 2.07% | |
| Pharma | 3.53% | |
| Pharma | 3.53% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHO Photocure | NOK 55.00 | 8.3% +NOK 113.8m | -15.6% | PE105.3x | |
| VISTN Vistin Pharma | NOK 23.80 | 3.9% +NOK 39.9m | -0.8% | PE17.2x | |
| SOFTX SoftOx Solutions | NOK 0.015 | 10.3% +NOK 2.7m | -99.1% | PS19.3x |